,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
101,WikiPathways_2019_Human,Hippo-Yap signaling pathway WP4537,1/23,0.0205073714570783,0.1026514532152333,0,0,53.36898395721925,207.44368622737056,MAP4K4
105,WikiPathways_2019_Human,Phosphodiesterases in neuronal function WP4222,1/53,0.0466597514614696,0.1026514532152333,0,0,22.54524886877828,69.09833217880467,PDE1C
104,WikiPathways_2019_Human,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,1/47,0.0414826184608072,0.1026514532152333,0,0,25.493606138107417,81.1329113370927,MAP4K4
103,WikiPathways_2019_Human,Sleep regulation WP3591,1/38,0.0336671099659209,0.1026514532152333,0,0,31.70906200317965,107.5328454820737,BTBD9
102,WikiPathways_2019_Human,Striated Muscle Contraction Pathway WP383,1/38,0.0336671099659209,0.1026514532152333,0,0,31.70906200317965,107.5328454820737,MYOM1
114,GO_Biological_Process_2017b,modulation of chemical synaptic transmission (GO:0050804),1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
113,GO_Biological_Process_2017b,modulation by symbiont of host synaptic transmission (GO:0044758),1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
112,GO_Biological_Process_2017b,protein kinase A signaling (GO:0010737),1/9,0.0080724193100501,0.1207971678969165,0,0,146.86764705882354,707.7995527019895,MYOM1
146,GO_Biological_Process_2017b,galactosaminoglycan catabolic process (GO:0006028),1/25,0.0222717298790694,0.1207971678969165,0,0,48.91666666666666,186.10038260880103,GPC5
148,GO_Biological_Process_2017b,peptidoglycan catabolic process (GO:0009253),1/26,0.0231527832149216,0.1207971678969165,0,0,46.95764705882353,176.82560723797164,GPC5
149,GO_Biological_Process_2017b,modulation of inhibitory postsynaptic potential (GO:0098828),1/26,0.0231527832149216,0.1207971678969165,0,0,46.95764705882353,176.82560723797164,BTBD9
150,GO_Biological_Process_2017b,mucopolysaccharide metabolic process (GO:1903510),1/28,0.0249126411012733,0.1207971678969165,0,0,43.474945533769066,160.52601632867996,GPC5
151,GO_Biological_Process_2017b,glycosaminoglycan metabolic process (GO:0030203),1/28,0.0249126411012733,0.1207971678969165,0,0,43.474945533769066,160.52601632867996,GPC5
145,GO_Biological_Process_2017b,dermatan sulfate catabolic process (GO:0030209),1/25,0.0222717298790694,0.1207971678969165,0,0,48.91666666666666,186.10038260880103,GPC5
152,GO_Biological_Process_2017b,galactosaminoglycan metabolic process (GO:0046350),1/28,0.0249126411012733,0.1207971678969165,0,0,43.474945533769066,160.52601632867996,GPC5
153,GO_Biological_Process_2017b,peptidoglycan metabolic process (GO:0000270),1/28,0.0249126411012733,0.1207971678969165,0,0,43.474945533769066,160.52601632867996,GPC5
154,GO_Biological_Process_2017b,positive regulation of pancreatic trypsinogen secretion (GO:1904244),1/29,0.02579144685281,0.1207971678969165,0,0,41.92016806722689,153.33191684558912,MYOM1
155,GO_Biological_Process_2017b,positive regulation of matrix metallopeptidase secretion (GO:1904466),1/29,0.02579144685281,0.1207971678969165,0,0,41.92016806722689,153.33191684558912,MYOM1
156,GO_Biological_Process_2017b,positive regulation of secretion of lysosomal enzymes (GO:0090340),1/29,0.02579144685281,0.1207971678969165,0,0,41.92016806722689,153.33191684558912,MYOM1
157,GO_Biological_Process_2017b,modulation of excitatory postsynaptic potential (GO:0098815),1/29,0.02579144685281,0.1207971678969165,0,0,41.92016806722689,153.33191684558912,BTBD9
158,GO_Biological_Process_2017b,positive regulation of BMP secretion (GO:1900144),1/29,0.02579144685281,0.1207971678969165,0,0,41.92016806722689,153.33191684558912,MYOM1
159,GO_Biological_Process_2017b,positive regulation of pancreatic amylase secretion (GO:1902278),1/29,0.02579144685281,0.1207971678969165,0,0,41.92016806722689,153.33191684558912,MYOM1
160,GO_Biological_Process_2017b,"regulation of translation at synapse, modulating synaptic transmission (GO:0099547)",1/30,0.0266695046006179,0.1207971678969165,0,0,40.47261663286004,146.68225415832842,BTBD9
161,GO_Biological_Process_2017b,chondroitin sulfate proteoglycan metabolic process (GO:0050654),1/30,0.0266695046006179,0.1207971678969165,0,0,40.47261663286004,146.68225415832842,GPC5
162,GO_Biological_Process_2017b,positive regulation of Wnt protein secretion (GO:0061357),1/30,0.0266695046006179,0.1207971678969165,0,0,40.47261663286004,146.68225415832842,MYOM1
144,GO_Biological_Process_2017b,striated muscle contraction involved in embryonic body morphogenesis (GO:0061199),1/25,0.0222717298790694,0.1207971678969165,0,0,48.91666666666666,186.10038260880103,MYOM1
115,GO_Biological_Process_2017b,regulation of neuromuscular synaptic transmission (GO:1900073),1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
116,GO_Biological_Process_2017b,"trans-synaptic signaling, modulating synaptic transmission (GO:0099550)",1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
147,GO_Biological_Process_2017b,heparin catabolic process (GO:0030211),1/25,0.0222717298790694,0.1207971678969165,0,0,48.91666666666666,186.10038260880103,GPC5
118,GO_Biological_Process_2017b,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
143,GO_Biological_Process_2017b,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/25,0.0222717298790694,0.1207971678969165,0,0,48.91666666666666,186.10038260880103,BTBD9
142,GO_Biological_Process_2017b,regulation of protein deubiquitination (GO:0090085),1/21,0.0187400067082949,0.1207971678969165,0,0,58.71176470588235,233.50224496360525,BTBD9
141,GO_Biological_Process_2017b,regulation of protein processing (GO:0070613),1/21,0.0187400067082949,0.1207971678969165,0,0,58.71176470588235,233.50224496360525,BTBD9
140,GO_Biological_Process_2017b,regulation of proteolysis (GO:0030162),1/21,0.0187400067082949,0.1207971678969165,0,0,58.71176470588235,233.50224496360525,BTBD9
139,GO_Biological_Process_2017b,regulation of peptidase activity (GO:0052547),1/21,0.0187400067082949,0.1207971678969165,0,0,58.71176470588235,233.50224496360525,BTBD9
138,GO_Biological_Process_2017b,regulation of protein desumoylation (GO:0060188),1/20,0.0178551954764704,0.1207971678969165,0,0,61.80495356037152,248.79341471282052,BTBD9
137,GO_Biological_Process_2017b,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/20,0.0178551954764704,0.1207971678969165,0,0,61.80495356037152,248.79341471282052,BTBD9
117,GO_Biological_Process_2017b,"regulation of modification of synapse structure, modulating synaptic transmission (GO:0098987)",1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
135,GO_Biological_Process_2017b,regulation of JUN kinase activity (GO:0043506),1/19,0.01696963087688,0.1207971678969165,0,0,65.24183006535948,265.9472259849427,MAP4K4
134,GO_Biological_Process_2017b,regulation of JNK cascade (GO:0046328),1/19,0.01696963087688,0.1207971678969165,0,0,65.24183006535948,265.9472259849427,MAP4K4
133,GO_Biological_Process_2017b,regulation of neurotransmitter secretion (GO:0046928),1/19,0.01696963087688,0.1207971678969165,0,0,65.24183006535948,265.9472259849427,BTBD9
132,GO_Biological_Process_2017b,"regulation of protein catabolic process at synapse, modulating synaptic transmission (GO:0099574)",1/19,0.01696963087688,0.1207971678969165,0,0,65.24183006535948,265.9472259849427,BTBD9
131,GO_Biological_Process_2017b,cardiac muscle myosin thick filament assembly (GO:0071690),1/18,0.0160833123117468,0.1207971678969165,0,0,69.08304498269896,285.3111137768628,MYOM1
136,GO_Biological_Process_2017b,regulation of protein deneddylation (GO:0060625),1/20,0.0178551954764704,0.1207971678969165,0,0,61.80495356037152,248.79341471282052,BTBD9
129,GO_Biological_Process_2017b,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/15,0.01341982690512,0.1207971678969165,0,0,83.89915966386555,361.6911269349327,BTBD9
130,GO_Biological_Process_2017b,striated muscle myosin thick filament assembly (GO:0071688),1/16,0.0143084109196949,0.1207971678969165,0,0,78.30196078431372,332.5412031884909,MYOM1
120,GO_Biological_Process_2017b,"regulation of synaptic transmission, cholinergic (GO:0032222)",1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
121,GO_Biological_Process_2017b,"regulation of synaptic transmission, glycinergic (GO:0060092)",1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
119,GO_Biological_Process_2017b,"modification of synaptic structure, modulating synaptic transmission (GO:0099564)",1/10,0.0089655500933473,0.1207971678969165,0,0,130.54248366013073,615.425022203049,BTBD9
123,GO_Biological_Process_2017b,negative regulation of synaptic transmission (GO:0050805),1/12,0.0107495345067081,0.1207971678969165,0,0,106.79679144385028,484.0984098875249,BTBD9
122,GO_Biological_Process_2017b,rhythmic synaptic transmission (GO:0060024),1/11,0.0098579216348164,0.1207971678969165,0,0,117.48235294117649,542.7073703814344,BTBD9
125,GO_Biological_Process_2017b,regulation of synaptic activity (GO:0060025),1/12,0.0107495345067081,0.1207971678969165,0,0,106.79679144385028,484.0984098875249,BTBD9
126,GO_Biological_Process_2017b,positive regulation of synaptic transmission (GO:0050806),1/13,0.011640389286531,0.1207971678969165,0,0,97.8921568627451,435.94063546940737,BTBD9
127,GO_Biological_Process_2017b,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1/13,0.011640389286531,0.1207971678969165,0,0,97.8921568627451,435.94063546940737,HS6ST3
128,GO_Biological_Process_2017b,skeletal muscle myosin thick filament assembly (GO:0030241),1/14,0.0125304865571366,0.1207971678969165,0,0,90.3574660633484,395.7287161899813,MYOM1
124,GO_Biological_Process_2017b,"regulation of synaptic transmission, dopaminergic (GO:0032225)",1/12,0.0107495345067081,0.1207971678969165,0,0,106.79679144385028,484.0984098875249,BTBD9
170,GO_Biological_Process_2017b,galactosaminoglycan biosynthetic process (GO:0006025),1/37,0.0327950148043916,0.1214555882545341,0,0,32.591503267973856,111.38077026649428,GPC5
174,GO_Biological_Process_2017b,chondroitin sulfate catabolic process (GO:0030207),1/39,0.0345384624837867,0.1214555882545341,0,0,30.87306501547988,103.9089106040704,GPC5
173,GO_Biological_Process_2017b,positive regulation of immunoglobulin secretion (GO:0051024),1/38,0.0336671099659209,0.1214555882545341,0,0,31.70906200317965,107.5328454820737,MYOM1
172,GO_Biological_Process_2017b,skeletal muscle contraction (GO:0003009),1/37,0.0327950148043916,0.1214555882545341,0,0,32.591503267973856,111.38077026649428,MYOM1
169,GO_Biological_Process_2017b,negative regulation of JNK cascade (GO:0046329),1/37,0.0327950148043916,0.1214555882545341,0,0,32.591503267973856,111.38077026649428,MAP4K4
164,GO_Biological_Process_2017b,"protein catabolic process, modulating synaptic transmission (GO:0099546)",1/33,0.0292991957903235,0.1214555882545341,0,0,36.67279411764706,129.4621221594897,BTBD9
167,GO_Biological_Process_2017b,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/34,0.030174267482518,0.1214555882545341,0,0,35.559714795008915,124.48623298308226,BTBD9
166,GO_Biological_Process_2017b,positive regulation of adiponectin secretion (GO:0070165),1/34,0.030174267482518,0.1214555882545341,0,0,35.559714795008915,124.48623298308226,MYOM1
165,GO_Biological_Process_2017b,positive regulation of prolactin secretion (GO:1902722),1/34,0.030174267482518,0.1214555882545341,0,0,35.559714795008915,124.48623298308226,MYOM1
163,GO_Biological_Process_2017b,positive regulation of renin secretion into blood stream (GO:1900135),1/31,0.0275468149406694,0.1214555882545341,0,0,39.12156862745098,140.51952455455398,MYOM1
176,GO_Biological_Process_2017b,heparin biosynthetic process (GO:0030210),1/40,0.035409072945574,0.1214555882545341,0,0,30.07993966817496,100.49067723322013,GPC5
168,GO_Biological_Process_2017b,keratan sulfate catabolic process (GO:0042340),1/36,0.0319221763964905,0.1214555882545341,0,0,33.52436974789916,115.4731604004656,GPC5
177,GO_Biological_Process_2017b,actin filament bundle organization (GO:0061572),1/40,0.035409072945574,0.1214555882545341,0,0,30.07993966817496,100.49067723322013,MYOM1
171,GO_Biological_Process_2017b,peptidoglycan biosynthetic process (GO:0009252),1/37,0.0327950148043916,0.1214555882545341,0,0,32.591503267973856,111.38077026649428,GPC5
179,GO_Biological_Process_2017b,hyaluronan catabolic process (GO:0030214),1/41,0.0362789419461595,0.1214555882545341,0,0,29.326470588235296,97.26176223664352,GPC5
178,GO_Biological_Process_2017b,actin filament branching (GO:0090135),1/41,0.0362789419461595,0.1214555882545341,0,0,29.326470588235296,97.26176223664352,MYOM1
175,GO_Biological_Process_2017b,actin filament organization (GO:0007015),1/40,0.035409072945574,0.1214555882545341,0,0,30.07993966817496,100.49067723322013,MYOM1
180,GO_Biological_Process_2017b,glycosaminoglycan catabolic process (GO:0006027),1/41,0.0362789419461595,0.1214555882545341,0,0,29.326470588235296,97.26176223664352,GPC5
182,GO_Biological_Process_2017b,hyaluronan biosynthetic process (GO:0030213),1/43,0.0380164579400951,0.121969469224472,0,0,27.92717086834734,91.3144790197023,GPC5
183,GO_Biological_Process_2017b,positive regulation of protein secretion (GO:0050714),1/43,0.0380164579400951,0.121969469224472,0,0,27.92717086834734,91.3144790197023,MYOM1
181,GO_Biological_Process_2017b,negative regulation of proteolysis (GO:0045861),1/42,0.0371480700853869,0.121969469224472,0,0,28.60975609756097,94.20744821276294,BTBD9
184,GO_Biological_Process_2017b,muscle thin filament assembly (GO:0071689),1/46,0.0406171857845244,0.1251009322163353,0,0,26.06143790849673,83.48948444789488,MYOM1
185,GO_Biological_Process_2017b,skeletal muscle thin filament assembly (GO:0030240),1/46,0.0406171857845244,0.1251009322163353,0,0,26.06143790849673,83.48948444789488,MYOM1
186,GO_Biological_Process_2017b,actin filament network formation (GO:0051639),1/46,0.0406171857845244,0.1251009322163353,0,0,26.06143790849673,83.48948444789488,MYOM1
187,GO_Biological_Process_2017b,glycosaminoglycan biosynthetic process (GO:0006024),1/48,0.0423473138141528,0.1263519485400096,0,0,24.94993742177722,78.88796682594588,GPC5
188,GO_Biological_Process_2017b,actin polymerization or depolymerization (GO:0008154),1/49,0.0432112724444188,0.1263519485400096,0,0,24.42892156862745,76.74721626832032,MYOM1
189,GO_Biological_Process_2017b,cardiac muscle thin filament assembly (GO:0071691),1/49,0.0432112724444188,0.1263519485400096,0,0,24.42892156862745,76.74721626832032,MYOM1
190,GO_Biological_Process_2017b,actin crosslink formation (GO:0051764),1/49,0.0432112724444188,0.1263519485400096,0,0,24.42892156862745,76.74721626832032,MYOM1
191,GO_Biological_Process_2017b,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/50,0.0440744949316926,0.12659076600299,0,0,23.92917166866747,74.70385911458476,GPC5
192,GO_Biological_Process_2017b,sarcomere organization (GO:0045214),1/51,0.0449369818711912,0.12659076600299,0,0,23.44941176470588,72.75166337328601,MYOM1
193,GO_Biological_Process_2017b,dermatan sulfate biosynthetic process (GO:0030208),1/51,0.0449369818711912,0.12659076600299,0,0,23.44941176470588,72.75166337328601,GPC5
194,GO_Biological_Process_2017b,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/52,0.0457987338494677,0.1274639460147837,0,0,22.988465974625143,70.88490801561363,PTPRT
95,KEGG_2019_Human,Taste transduction,1/83,0.0721516995917754,0.130704613491688,0,0,14.275466284074604,37.52997870137401,PDE1C
97,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0871364089944587,0.130704613491688,0,0,11.69529411764706,28.539797811620943,SPATA5
96,KEGG_2019_Human,Morphine addiction,1/91,0.0788400249120094,0.130704613491688,0,0,13.001307189542484,33.02766894797317,PDE1C
93,KEGG_2019_Human,Olfactory transduction,2/444,0.0595300690031704,0.130704613491688,0,0,5.526018099547511,15.590409710594148,PDE1C;NCALD
94,KEGG_2019_Human,Renin secretion,1/69,0.0603366373648496,0.130704613491688,0,0,17.226643598615915,48.3692416453001,PDE1C
92,KEGG_2019_Human,Glycosaminoglycan biosynthesis,1/53,0.0466597514614696,0.130704613491688,0,0,22.54524886877828,69.09833217880467,HS6ST3
236,GO_Biological_Process_2017b,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/83,0.0721516995917754,0.1311867967124895,0,0,14.275466284074604,37.52997870137401,PTPRT
222,GO_Biological_Process_2017b,vesicle-mediated cholesterol transport (GO:0090119),1/75,0.0654175289767128,0.1311867967124895,0,0,15.825119236883944,43.154546742931096,NCALD
223,GO_Biological_Process_2017b,brain-derived neurotrophic factor receptor signaling pathway (GO:0031547),1/75,0.0654175289767128,0.1311867967124895,0,0,15.825119236883944,43.154546742931096,PTPRT
224,GO_Biological_Process_2017b,Golgi vesicle transport (GO:0048193),1/76,0.0662618175517913,0.1311867967124895,0,0,15.613333333333332,42.376795202067306,NCALD
225,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0662618175517913,0.1311867967124895,0,0,15.613333333333332,42.376795202067306,PTPRT
241,GO_Biological_Process_2017b,trigeminal sensory nucleus development (GO:0021730),1/85,0.0738280674139551,0.1311867967124895,0,0,13.934173669467787,36.31268374332498,SPATA5
226,GO_Biological_Process_2017b,transcytosis (GO:0045056),1/76,0.0662618175517913,0.1311867967124895,0,0,15.613333333333332,42.376795202067306,NCALD
240,GO_Biological_Process_2017b,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/85,0.0738280674139551,0.1311867967124895,0,0,13.934173669467787,36.31268374332498,PTPRT
227,GO_Biological_Process_2017b,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/76,0.0662618175517913,0.1311867967124895,0,0,15.613333333333332,42.376795202067306,PTPRT
228,GO_Biological_Process_2017b,plasma membrane to endosome transport (GO:0048227),1/77,0.0671053857579431,0.1311867967124895,0,0,15.407120743034056,41.62219761611141,NCALD
229,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/77,0.0671053857579431,0.1311867967124895,0,0,15.407120743034056,41.62219761611141,PTPRT
231,GO_Biological_Process_2017b,growth hormone receptor signaling pathway (GO:0060396),1/80,0.0696317739420862,0.1311867967124895,0,0,14.819806403574088,39.48788238772356,PTPRT
232,GO_Biological_Process_2017b,neurotrophin TRK receptor signaling pathway (GO:0048011),1/80,0.0696317739420862,0.1311867967124895,0,0,14.819806403574088,39.48788238772356,PTPRT
233,GO_Biological_Process_2017b,insulin-like growth factor receptor signaling pathway (GO:0048009),1/82,0.0713124414727928,0.1311867967124895,0,0,14.452432824981845,38.16431494463284,PTPRT
234,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0721516995917754,0.1311867967124895,0,0,14.275466284074604,37.52997870137401,PTPRT
235,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0721516995917754,0.1311867967124895,0,0,14.275466284074604,37.52997870137401,PTPRT
239,GO_Biological_Process_2017b,brain segmentation (GO:0035284),1/85,0.0738280674139551,0.1311867967124895,0,0,13.934173669467787,36.31268374332498,SPATA5
238,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0729902413804037,0.1311867967124895,0,0,14.10276399716513,36.91299089130259,PTPRT
237,GO_Biological_Process_2017b,actin filament reorganization (GO:0090527),1/84,0.0729902413804037,0.1311867967124895,0,0,14.10276399716513,36.91299089130259,MYOM1
221,GO_Biological_Process_2017b,cargo loading into vesicle (GO:0035459),1/74,0.0645725194547735,0.1311867967124895,0,0,16.042707493956488,43.95647876269956,NCALD
230,GO_Biological_Process_2017b,multivesicular body sorting pathway (GO:0071985),1/80,0.0696317739420862,0.1311867967124895,0,0,14.819806403574088,39.48788238772356,NCALD
220,GO_Biological_Process_2017b,actin nucleation (GO:0045010),1/74,0.0645725194547735,0.1311867967124895,0,0,16.042707493956488,43.95647876269956,MYOM1
212,GO_Biological_Process_2017b,vesicle uncoating (GO:0072319),1/71,0.0620331594172908,0.1311867967124895,0,0,16.7327731092437,46.51855173584374,NCALD
218,GO_Biological_Process_2017b,Tie signaling pathway (GO:0048014),1/74,0.0645725194547735,0.1311867967124895,0,0,16.042707493956488,43.95647876269956,PTPRT
195,GO_Biological_Process_2017b,positive regulation of proteolysis (GO:0045862),1/55,0.0483795859097418,0.1311867967124895,0,0,21.70806100217865,65.7467122997584,BTBD9
196,GO_Biological_Process_2017b,cardiac muscle contraction (GO:0060048),1/57,0.0500964899328297,0.1311867967124895,0,0,20.930672268907564,62.66233736405012,MYOM1
197,GO_Biological_Process_2017b,chondroitin sulfate biosynthetic process (GO:0030206),1/59,0.051810468206973,0.1311867967124895,0,0,20.20689655172414,59.81570875382696,GPC5
198,GO_Biological_Process_2017b,retinoid metabolic process (GO:0001523),1/59,0.051810468206973,0.1311867967124895,0,0,20.20689655172414,59.81570875382696,GPC5
199,GO_Biological_Process_2017b,vitamin A metabolic process (GO:0006776),1/60,0.0526663616642541,0.1311867967124895,0,0,19.863409770687937,58.47347515993359,GPC5
200,GO_Biological_Process_2017b,retinal metabolic process (GO:0042574),1/63,0.0552296663042342,0.1311867967124895,0,0,18.89943074003795,54.73757147758474,GPC5
201,GO_Biological_Process_2017b,retinol metabolic process (GO:0042572),1/63,0.0552296663042342,0.1311867967124895,0,0,18.89943074003795,54.73757147758474,GPC5
219,GO_Biological_Process_2017b,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),1/74,0.0645725194547735,0.1311867967124895,0,0,16.042707493956488,43.95647876269956,PTPRT
203,GO_Biological_Process_2017b,keratan sulfate biosynthetic process (GO:0018146),1/65,0.0569348954637786,0.1311867967124895,0,0,18.30698529411765,52.46501611587855,GPC5
204,GO_Biological_Process_2017b,plastid to vacuole vesicle-mediated transport (GO:1904962),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
202,GO_Biological_Process_2017b,positive regulation of cytokine secretion (GO:0050715),1/65,0.0569348954637786,0.1311867967124895,0,0,18.30698529411765,52.46501611587855,MYOM1
206,GO_Biological_Process_2017b,vesicle-mediated transport in synapse (GO:0099003),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
217,GO_Biological_Process_2017b,sevenless signaling pathway (GO:0045500),1/72,0.0628803352568931,0.1311867967124895,0,0,16.496271748135875,45.63729539644487,PTPRT
205,GO_Biological_Process_2017b,endocytic import into cell (GO:0098701),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
215,GO_Biological_Process_2017b,"retrograde transport, plasma membrane to Golgi (GO:0035526)",1/72,0.0628803352568931,0.1311867967124895,0,0,16.496271748135875,45.63729539644487,NCALD
214,GO_Biological_Process_2017b,positive regulation of JNK cascade (GO:0046330),1/72,0.0628803352568931,0.1311867967124895,0,0,16.496271748135875,45.63729539644487,MAP4K4
216,GO_Biological_Process_2017b,SNARE complex disassembly (GO:0035494),1/72,0.0628803352568931,0.1311867967124895,0,0,16.496271748135875,45.63729539644487,NCALD
211,GO_Biological_Process_2017b,vesicle-mediated transport to the plasma membrane (GO:0098876),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
209,GO_Biological_Process_2017b,contractile vacuole dissociation from plasma membrane (GO:0140026),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
208,GO_Biological_Process_2017b,vesicle-mediated transport (GO:0016192),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
207,GO_Biological_Process_2017b,vesicle-mediated transport between endosomal compartments (GO:0098927),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
213,GO_Biological_Process_2017b,retinoic acid metabolic process (GO:0042573),1/72,0.0628803352568931,0.1311867967124895,0,0,16.496271748135875,45.63729539644487,GPC5
210,GO_Biological_Process_2017b,mitochondrion-derived vesicle mediated transport (GO:0099075),1/70,0.0611852603166933,0.1311867967124895,0,0,16.97612958226769,47.42874202866335,NCALD
242,GO_Biological_Process_2017b,ventricular system development (GO:0021591),1/87,0.075501574519904,0.133035702145705,0,0,13.60875512995896,35.15960381916263,SPATA5
243,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0763372567298681,0.133035702145705,0,0,13.451656524678835,34.60565311468726,PTPRT
244,GO_Biological_Process_2017b,vesicle docking (GO:0048278),1/89,0.0771722254871189,0.133035702145705,0,0,13.29812834224599,34.06602362525984,NCALD
245,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0771722254871189,0.133035702145705,0,0,13.29812834224599,34.06602362525984,PTPRT
246,GO_Biological_Process_2017b,vascular endothelial growth factor signaling pathway (GO:0038084),1/90,0.0780064813617029,0.1334777569966918,0,0,13.148050231328488,33.54019441349092,PTPRT
0,GO_Biological_Process_2018,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1/6,0.0053884659389882,0.1338644767951071,0,0,235.0235294117647,1227.644124299904,HS6ST3
3,GO_Biological_Process_2018,skeletal muscle thin filament assembly (GO:0030240),1/10,0.0089655500933473,0.1338644767951071,0,0,130.54248366013073,615.425022203049,MYOM1
7,GO_Biological_Process_2018,striated muscle myosin thick filament assembly (GO:0071688),1/13,0.011640389286531,0.1338644767951071,0,0,97.8921568627451,435.94063546940737,MYOM1
6,GO_Biological_Process_2018,skeletal myofibril assembly (GO:0014866),1/12,0.0107495345067081,0.1338644767951071,0,0,106.79679144385028,484.0984098875249,MYOM1
5,GO_Biological_Process_2018,cardiac muscle fiber development (GO:0048739),1/12,0.0107495345067081,0.1338644767951071,0,0,106.79679144385028,484.0984098875249,MYOM1
2,GO_Biological_Process_2018,protein kinase A signaling (GO:0010737),1/10,0.0089655500933473,0.1338644767951071,0,0,130.54248366013073,615.425022203049,MYOM1
1,GO_Biological_Process_2018,skeletal muscle myosin thick filament assembly (GO:0030241),1/7,0.0062838777740325,0.1338644767951071,0,0,195.843137254902,992.8792720611536,MYOM1
4,GO_Biological_Process_2018,myosin filament assembly (GO:0031034),1/11,0.0098579216348164,0.1338644767951071,0,0,117.48235294117649,542.7073703814344,MYOM1
247,GO_Biological_Process_2017b,vesicle budding from membrane (GO:0006900),1/92,0.0796728567374856,0.1343389044259794,0,0,12.857789269553976,32.527973699604026,NCALD
248,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.0796728567374856,0.1343389044259794,0,0,12.857789269553976,32.527973699604026,PTPRT
249,GO_Biological_Process_2017b,brain morphogenesis (GO:0048854),1/94,0.0813363874441795,0.1361500398522136,0,0,12.58001265022138,31.565287091339385,SPATA5
8,GO_Biological_Process_2018,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/15,0.01341982690512,0.1368898319862732,0,0,83.89915966386555,361.6911269349327,HS6ST3
11,GO_Biological_Process_2018,heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,0.0178551954764704,0.1368898319862732,0,0,61.80495356037152,248.79341471282052,HS6ST3
9,GO_Biological_Process_2018,cardiac myofibril assembly (GO:0055003),1/17,0.0151962391911868,0.1368898319862732,0,0,73.40441176470588,307.3227868353231,MYOM1
10,GO_Biological_Process_2018,muscle tissue morphogenesis (GO:0060415),1/19,0.01696963087688,0.1368898319862732,0,0,65.24183006535948,265.9472259849427,MYOM1
250,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.083826359716664,0.1393085546370459,0,0,12.185049019607844,30.20683114705019,PTPRT
42,GO_Biological_Process_2018,negative regulation of inflammatory response (GO:0050728),1/78,0.0679482341709108,0.1395903109680199,0,0,15.206264323911382,40.88978353793229,NLRP11
43,GO_Biological_Process_2018,negative regulation of defense response (GO:0031348),1/80,0.0696317739420862,0.1395903109680199,0,0,14.819806403574088,39.48788238772356,NLRP11
41,GO_Biological_Process_2018,regulation of defense response (GO:0031347),1/75,0.0654175289767128,0.1395903109680199,0,0,15.825119236883944,43.154546742931096,NLRP11
40,GO_Biological_Process_2018,retinoid metabolic process (GO:0001523),1/75,0.0654175289767128,0.1395903109680199,0,0,15.825119236883944,43.154546742931096,GPC5
39,GO_Biological_Process_2018,actomyosin structure organization (GO:0031032),1/71,0.0620331594172908,0.1395903109680199,0,0,16.7327731092437,46.51855173584374,MYOM1
38,GO_Biological_Process_2018,regulation of cell communication (GO:0010646),1/71,0.0620331594172908,0.1395903109680199,0,0,16.7327731092437,46.51855173584374,BTBD9
37,GO_Biological_Process_2018,stress-activated protein kinase signaling cascade (GO:0031098),1/70,0.0611852603166933,0.1395903109680199,0,0,16.97612958226769,47.42874202866335,MAP4K4
44,GO_Biological_Process_2018,positive regulation of protein secretion (GO:0050714),1/82,0.0713124414727928,0.1395903109680199,0,0,14.452432824981845,38.16431494463284,MYOM1
45,GO_Biological_Process_2018,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/82,0.0713124414727928,0.1395903109680199,0,0,14.452432824981845,38.16431494463284,NLRP11
32,GO_Biological_Process_2018,glycosaminoglycan metabolic process (GO:0030203),1/61,0.0535215254426699,0.1395903109680199,0,0,19.531372549019608,57.18144005818292,GPC5
26,GO_Biological_Process_2018,positive regulation of secretion by cell (GO:1903532),1/52,0.0457987338494677,0.1395903109680199,0,0,22.988465974625143,70.88490801561363,MYOM1
27,GO_Biological_Process_2018,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.0457987338494677,0.1395903109680199,0,0,22.988465974625143,70.88490801561363,MAP4K4
28,GO_Biological_Process_2018,positive regulation of protein transport (GO:0051222),1/56,0.0492384039303871,0.1395903109680199,0,0,21.31229946524064,64.173068346434,MYOM1
46,GO_Biological_Process_2018,modulation of chemical synaptic transmission (GO:0050804),1/82,0.0713124414727928,0.1395903109680199,0,0,14.452432824981845,38.16431494463284,BTBD9
29,GO_Biological_Process_2018,glycosaminoglycan catabolic process (GO:0006027),1/56,0.0492384039303871,0.1395903109680199,0,0,21.31229946524064,64.173068346434,GPC5
30,GO_Biological_Process_2018,regulation of protein metabolic process (GO:0051246),1/59,0.051810468206973,0.1395903109680199,0,0,20.20689655172414,59.81570875382696,BTBD9
36,GO_Biological_Process_2018,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/70,0.0611852603166933,0.1395903109680199,0,0,16.97612958226769,47.42874202866335,BTBD9
35,GO_Biological_Process_2018,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/64,0.0560826445470321,0.1395903109680199,0,0,18.598506069094302,53.58097327195968,PTPRT
34,GO_Biological_Process_2018,regulation of proteolysis (GO:0030162),1/63,0.0552296663042342,0.1395903109680199,0,0,18.89943074003795,54.73757147758474,BTBD9
33,GO_Biological_Process_2018,diterpenoid metabolic process (GO:0016101),1/62,0.0543759601292243,0.1395903109680199,0,0,19.210221793635487,55.93696029523851,GPC5
31,GO_Biological_Process_2018,striated muscle contraction (GO:0006941),1/61,0.0535215254426699,0.1395903109680199,0,0,19.531372549019608,57.18144005818292,MYOM1
25,GO_Biological_Process_2018,heart morphogenesis (GO:0003007),1/50,0.0440744949316926,0.1395903109680199,0,0,23.92917166866747,74.70385911458476,MYOM1
24,GO_Biological_Process_2018,myofibril assembly (GO:0030239),1/47,0.0414826184608072,0.1395903109680199,0,0,25.493606138107417,81.1329113370927,MYOM1
22,GO_Biological_Process_2018,negative regulation of immune system process (GO:0002683),1/44,0.0388841061194349,0.1395903109680199,0,0,27.276333789329687,88.57088446864675,NLRP11
12,GO_Biological_Process_2018,cardiac muscle cell development (GO:0055013),1/27,0.0240330867565966,0.1395903109680199,0,0,45.14932126696833,168.33128827465845,MYOM1
13,GO_Biological_Process_2018,muscle fiber development (GO:0048747),1/27,0.0240330867565966,0.1395903109680199,0,0,45.14932126696833,168.33128827465845,MYOM1
14,GO_Biological_Process_2018,aminoglycan metabolic process (GO:0006022),1/30,0.0266695046006179,0.1395903109680199,0,0,40.47261663286004,146.68225415832842,GPC5
15,GO_Biological_Process_2018,sarcomere organization (GO:0045214),1/31,0.0275468149406694,0.1395903109680199,0,0,39.12156862745098,140.51952455455398,MYOM1
16,GO_Biological_Process_2018,aminoglycan catabolic process (GO:0006026),1/32,0.0284233784701102,0.1395903109680199,0,0,37.85768500948767,134.79392621731594,GPC5
17,GO_Biological_Process_2018,positive regulation of peptide secretion (GO:0002793),1/35,0.0310485941558708,0.1395903109680199,0,0,34.5121107266436,119.83301120641356,MYOM1
23,GO_Biological_Process_2018,aminoglycan biosynthetic process (GO:0006023),1/46,0.0406171857845244,0.1395903109680199,0,0,26.06143790849673,83.48948444789488,GPC5
19,GO_Biological_Process_2018,cardiac muscle tissue morphogenesis (GO:0055008),1/36,0.0319221763964905,0.1395903109680199,0,0,33.52436974789916,115.4731604004656,MYOM1
20,GO_Biological_Process_2018,regulation of stress-activated MAPK cascade (GO:0032872),1/41,0.0362789419461595,0.1395903109680199,0,0,29.326470588235296,97.26176223664352,MAP4K4
21,GO_Biological_Process_2018,negative regulation of immune response (GO:0050777),1/44,0.0388841061194349,0.1395903109680199,0,0,27.276333789329687,88.57088446864675,NLRP11
18,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0319221763964905,0.1395903109680199,0,0,33.52436974789916,115.4731604004656,MYOM1
98,KEGG_2019_Human,Purine metabolism,1/129,0.1099924714179828,0.1414188918231208,0,0,9.124080882352942,20.13997932609556,PDE1C
251,GO_Biological_Process_2017b,striated muscle contraction (GO:0006941),1/102,0.0879621547820787,0.1451375553904299,0,0,11.578916715200933,28.146593675405043,MYOM1
106,WikiPathways_2019_Human,G Protein Signaling Pathways WP35,1/93,0.0805049773808957,0.1475924585316421,0,0,12.717391304347826,32.040656856642045,PDE1C
47,GO_Biological_Process_2018,regulation of JNK cascade (GO:0046328),1/90,0.0780064813617029,0.1495124226099307,0,0,13.148050231328488,33.54019441349092,MAP4K4
252,GO_Biological_Process_2017b,positive regulation of insulin secretion (GO:0032024),1/111,0.0953621885731626,0.1562316706411387,0,0,10.62673796791444,24.97361130786349,MYOM1
253,GO_Biological_Process_2017b,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/112,0.0961809050976451,0.1564633033630706,0,0,10.530471648118708,24.657356652146078,PTPRT
48,GO_Biological_Process_2018,glycosaminoglycan biosynthetic process (GO:0006024),1/99,0.0854827987095899,0.1604983159445362,0,0,11.935174069627852,29.35384580236193,GPC5
51,GO_Biological_Process_2018,regulation of protein secretion (GO:0050708),1/107,0.0920803129872449,0.1612635616423835,0,0,11.029966703662597,26.30750867900853,MYOM1
50,GO_Biological_Process_2018,regulation of response to external stimulus (GO:0032101),1/107,0.0920803129872449,0.1612635616423835,0,0,11.029966703662597,26.30750867900853,NLRP11
52,GO_Biological_Process_2018,regulation of cytokine production (GO:0001817),1/108,0.0929018344244166,0.1612635616423835,0,0,10.926333150082463,25.96328271398022,NLRP11
49,GO_Biological_Process_2018,negative regulation of response to external stimulus (GO:0032102),1/107,0.0920803129872449,0.1612635616423835,0,0,11.029966703662597,26.30750867900853,NLRP11
55,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.1027054909715507,0.168655122840907,0,0,9.818586258032624,22.3460193071682,PTPRT
58,GO_Biological_Process_2018,negative regulation of response to stimulus (GO:0048585),1/127,0.1083779888894848,0.168655122840907,0,0,9.26984126984127,20.598794838572697,NLRP11
59,GO_Biological_Process_2018,regulation of macromolecule metabolic process (GO:0060255),1/129,0.1099924714179828,0.168655122840907,0,0,9.124080882352942,20.13997932609556,NLRP11
54,GO_Biological_Process_2018,actin filament organization (GO:0007015),1/120,0.1027054909715507,0.168655122840907,0,0,9.818586258032624,22.3460193071682,MYOM1
53,GO_Biological_Process_2018,brain development (GO:0007420),1/119,0.1018923572787402,0.168655122840907,0,0,9.902293120638086,22.615236719842347,SPATA5
56,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.1059510780315295,0.168655122840907,0,0,9.49736967957915,21.31948479946905,PTPRT
57,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1067607406651116,0.168655122840907,0,0,9.420303605313093,21.074773673487663,PTPRT
60,GO_Biological_Process_2018,muscle contraction (GO:0006936),1/137,0.1164228335754234,0.1755885358842451,0,0,8.583910034602075,18.459926845841217,MYOM1
61,GO_Biological_Process_2018,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/140,0.118822887239702,0.1758506998757228,0,0,8.39737621667372,17.887429414854076,NLRP11
62,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/142,0.1204195010018536,0.1758506998757228,0,0,8.277430120984564,17.521447135021635,PTPRT
99,KEGG_2019_Human,Calcium signaling pathway,1/188,0.1563962949509336,0.1759458318198003,0,0,6.22680088078012,11.552970612023575,PDE1C
107,WikiPathways_2019_Human,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,1/132,0.1124090192777675,0.176642744579349,0,0,8.913785361472833,19.48206824738867,MAP4K4
255,GO_Biological_Process_2017b,endocytosis (GO:0006897),1/131,0.1116041927175137,0.1790317258176783,0,0,8.982805429864253,19.697465749311625,NCALD
254,GO_Biological_Process_2017b,vesicle fusion (GO:0006906),1/131,0.1116041927175137,0.1790317258176783,0,0,8.982805429864253,19.697465749311625,NCALD
256,GO_Biological_Process_2017b,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/133,0.1132131572099071,0.1803602711413003,0,0,8.845811051693405,19.27044802603592,PTPRT
257,GO_Biological_Process_2017b,late endosome to vacuole transport (GO:0045324),1/135,0.1148193693672815,0.1816662624920687,0,0,8.712906057945567,18.858171061974925,NCALD
110,WikiPathways_2019_Human,Circadian rhythm related genes WP3594,1/201,0.1663089555580513,0.1829398511138565,0,0,5.818235294117647,10.437379086756568,BTBD9
109,WikiPathways_2019_Human,Metapathway biotransformation Phase I and II WP702,1/183,0.1525541767130676,0.1829398511138565,0,0,6.399482870071106,12.03253480284285,HS6ST3
108,WikiPathways_2019_Human,Insulin Signaling WP481,1/160,0.1346665906377369,0.1829398511138565,0,0,7.33370329263781,14.70373228235524,MAP4K4
64,GO_Biological_Process_2018,regulation of mitotic cell cycle (GO:0007346),1/165,0.1385852664967363,0.1924420835569138,0,0,7.10832137733142,14.047958735704976,MAP4K4
65,GO_Biological_Process_2018,regulation of inflammatory response (GO:0050727),1/166,0.139366987817599,0.1924420835569138,0,0,7.06488413547237,13.922375947326568,NLRP11
66,GO_Biological_Process_2018,neuron projection development (GO:0031175),1/167,0.1401480391121003,0.1924420835569138,0,0,7.021970233876683,13.798564689487431,MAP4K4
63,GO_Biological_Process_2018,neuron projection morphogenesis (GO:0048812),1/163,0.1370198116411668,0.1924420835569138,0,0,7.19680464778504,14.304583045111348,MAP4K4
258,GO_Biological_Process_2017b,neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968),1/146,0.1236045355363844,0.1942356987000327,0,0,8.047464503042596,16.82457683434384,NCALD
67,GO_Biological_Process_2018,positive regulation of protein kinase activity (GO:0045860),1/172,0.1440432641663662,0.1948820632839073,0,0,6.814929480564156,13.204890719024512,MAP4K4
259,GO_Biological_Process_2017b,endocytic recycling (GO:0032456),1/149,0.1259861598669261,0.1966405603328374,0,0,7.883147853736089,16.33059681765117,NCALD
260,GO_Biological_Process_2017b,ephrin receptor signaling pathway (GO:0048013),1/151,0.1275705121508778,0.1977771027305555,0,0,7.777254901960784,16.014036926399935,PTPRT
111,WikiPathways_2019_Human,MAPK Signaling Pathway WP382,1/246,0.1997792661980576,0.1997792661980576,0,0,4.738775510204082,7.631997892552949,MAP4K4
261,GO_Biological_Process_2017b,Kit signaling pathway (GO:0038109),1/163,0.1370198116411668,0.2110105099273969,0,0,7.19680464778504,14.304583045111348,PTPRT
262,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway (GO:0008543),1/166,0.139366987817599,0.2132038025553998,0,0,7.06488413547237,13.922375947326568,PTPRT
263,GO_Biological_Process_2017b,brain development (GO:0007420),1/174,0.1455966829399851,0.2209936136978762,0,0,6.735464127847671,12.97866635801621,SPATA5
264,GO_Biological_Process_2017b,endosome to lysosome transport (GO:0008333),1/175,0.1463723934882037,0.2209936136978762,0,0,6.696416497633536,12.867842408171857,NCALD
265,GO_Biological_Process_2017b,insulin receptor signaling pathway (GO:0008286),1/177,0.1479218196071764,0.2218827294107647,0,0,6.619652406417113,12.650628330192763,PTPRT
68,GO_Biological_Process_2018,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/204,0.1685808180869165,0.2247744241158887,0,0,5.731382208055636,10.203809066850312,NLRP11
266,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1548614260771356,0.2307934801536666,0,0,6.294753577106518,11.741129142703194,PTPRT
69,GO_Biological_Process_2018,regulation of cell cycle (GO:0051726),1/215,0.1768610562307949,0.2311119839837317,0,0,5.4337548103353495,9.413387102196012,MAP4K4
70,GO_Biological_Process_2018,central nervous system development (GO:0007417),1/217,0.1783581615526625,0.2311119839837317,0,0,5.382897603485839,9.279908801665458,SPATA5
267,GO_Biological_Process_2017b,protein denaturation involved in proteasomal ubiquitin-dependent protein catabolic process (GO:1902376),1/192,0.159458138303734,0.2320726863969184,0,0,6.095164767477672,11.190563106127478,BTBD9
268,GO_Biological_Process_2017b,ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),1/192,0.159458138303734,0.2320726863969184,0,0,6.095164767477672,11.190563106127478,BTBD9
272,GO_Biological_Process_2017b,ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),1/195,0.1617476299130038,0.2320726863969184,0,0,6.0,10.93030799092462,BTBD9
270,GO_Biological_Process_2017b,transcription factor catabolic process (GO:0036369),1/194,0.1609851212681268,0.2320726863969184,0,0,6.03139286802804,11.01599729101681,BTBD9
271,GO_Biological_Process_2017b,"retrograde transport, endosome to Golgi (GO:0042147)",1/194,0.1609851212681268,0.2320726863969184,0,0,6.03139286802804,11.01599729101681,NCALD
269,GO_Biological_Process_2017b,mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671),1/193,0.1602219575794502,0.2320726863969184,0,0,6.06311274509804,11.102742896452275,BTBD9
273,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome (GO:0071629),1/198,0.1640312309017046,0.2338963848042825,0,0,5.907733651836369,10.679400888402991,BTBD9
274,GO_Biological_Process_2017b,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome (GO:0071630),1/200,0.1655503660358053,0.2342522483774991,0,0,5.847768253029855,10.51709310132786,BTBD9
275,GO_Biological_Process_2017b,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/201,0.1663089555580513,0.2342522483774991,0,0,5.818235294117647,10.437379086756568,BTBD9
100,KEGG_2019_Human,MAPK signaling pathway,1/295,0.234779716163076,0.234779716163076,0,0,3.9391756702681073,5.708289332510074,MAP4K4
279,GO_Biological_Process_2017b,positive regulation of histone gene expression (GO:0036207),1/214,0.1761115378256675,0.2385342673341691,0,0,5.459541563104115,9.48124595993874,MYOM1
281,GO_Biological_Process_2017b,positive regulation of production of siRNA involved in RNA interference (GO:1903705),1/215,0.1768610562307949,0.2385342673341691,0,0,5.4337548103353495,9.413387102196012,MYOM1
280,GO_Biological_Process_2017b,negative regulation of mRNA catabolic process (GO:1902373),1/215,0.1768610562307949,0.2385342673341691,0,0,5.4337548103353495,9.413387102196012,MYOM1
282,GO_Biological_Process_2017b,positive regulation of rhodopsin gene expression (GO:0045872),1/215,0.1768610562307949,0.2385342673341691,0,0,5.4337548103353495,9.413387102196012,MYOM1
276,GO_Biological_Process_2017b,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1/207,0.1708468326974516,0.2385342673341691,0,0,5.647058823529412,9.978284267811627,BTBD9
277,GO_Biological_Process_2017b,positive regulation of tRNA processing (GO:2000237),1/214,0.1761115378256675,0.2385342673341691,0,0,5.459541563104115,9.48124595993874,MYOM1
278,GO_Biological_Process_2017b,positive regulation of snoRNA processing (GO:1902798),1/214,0.1761115378256675,0.2385342673341691,0,0,5.459541563104115,9.48124595993874,MYOM1
283,GO_Biological_Process_2017b,negative regulation of gene silencing (GO:0060969),1/216,0.1776099306557449,0.2385342673341691,0,0,5.4082079343365255,9.346278553544366,MYOM1
284,GO_Biological_Process_2017b,positive regulation of rRNA processing (GO:2000234),1/220,0.1805989985455345,0.2411466396764074,0,0,5.3083534783776525,9.085120550073489,MYOM1
285,GO_Biological_Process_2017b,positive regulation of protein maturation (GO:1903319),1/222,0.1820896819502316,0.2417397501753075,0,0,5.259781740750599,8.958754573524155,MYOM1
286,GO_Biological_Process_2017b,positive regulation of mRNA processing (GO:0050685),1/224,0.1835778038697192,0.2423227011080294,0,0,5.212081245054075,8.835085970983735,MYOM1
71,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.1902427648031118,0.2430879772484206,0,0,5.007606490872211,8.309894188622586,MAP4K4
72,GO_Biological_Process_2018,proteasomal protein catabolic process (GO:0010498),1/237,0.193188445176418,0.2434703692634309,0,0,4.921734795613161,8.091770858187086,BTBD9
287,GO_Biological_Process_2017b,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/227,0.1858051929744343,0.243869315778945,0,0,5.142113482561166,8.654467539704264,MYOM1
73,GO_Biological_Process_2018,regulation of immune response (GO:0050776),1/251,0.2034188278758055,0.2504176969687209,0,0,4.642823529411765,7.393641842618357,NLRP11
74,GO_Biological_Process_2018,inflammatory response (GO:0006954),1/252,0.2041448616592834,0.2504176969687209,0,0,4.624091867822826,7.3473371639301455,NLRP11
290,GO_Biological_Process_2017b,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/249,0.2019648832812864,0.2606362460222188,0,0,4.680740037950664,7.487599357967169,BTBD9
288,GO_Biological_Process_2017b,ubiquitin-dependent ERAD pathway (GO:0030433),1/247,0.2005084325946525,0.2606362460222188,0,0,4.719273075083692,7.583395068471468,BTBD9
289,GO_Biological_Process_2017b,positive regulation of RNA splicing (GO:0033120),1/248,0.2012369714281934,0.2606362460222188,0,0,4.699928554417719,7.535264337504203,MYOM1
75,GO_Biological_Process_2018,regulation of programmed cell death (GO:0043067),1/268,0.2156767451360984,0.2610823756910665,0,0,4.343467724168319,6.6627689152345,MAP4K4
76,GO_Biological_Process_2018,positive regulation of macromolecule metabolic process (GO:0010604),1/276,0.2213833313175022,0.2627942708588414,0,0,4.215401069518717,6.356232756286204,MYOM1
77,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.2228038383368437,0.2627942708588414,0,0,4.184540242089616,6.282934619193975,MAP4K4
78,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),2/1001,0.2267883512305013,0.264107953331723,0,0,2.37525025025025,3.5242492217529624,PTPRT;MAP4K4
79,GO_Biological_Process_2018,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/291,0.2319776449395972,0.2667742916805368,0,0,3.994320486815416,5.836158662149624,BTBD9
291,GO_Biological_Process_2017b,"positive regulation of gene expression, epigenetic (GO:0045815)",1/261,0.2106511011997868,0.2703355798730598,0,0,4.4619909502262445,6.94978320935797,MYOM1
80,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),2/1037,0.2389479864309017,0.2713977129832464,0,0,2.2882850241545896,3.2757014778651543,MYOM1;NLRP11
314,GO_Biological_Process_2017b,negative regulation of apoptotic process in bone marrow (GO:0071866),1/325,0.2554895831809807,0.2815028085978937,0,0,3.5689905591866378,4.870150440253562,MAP4K4
313,GO_Biological_Process_2017b,negative regulation of apoptotic process involved in development (GO:1904746),1/325,0.2554895831809807,0.2815028085978937,0,0,3.5689905591866378,4.870150440253562,MAP4K4
312,GO_Biological_Process_2017b,negative regulation of myofibroblast cell apoptotic process (GO:1904521),1/325,0.2554895831809807,0.2815028085978937,0,0,3.5689905591866378,4.870150440253562,MAP4K4
311,GO_Biological_Process_2017b,negative regulation of compound eye retinal cell apoptotic process (GO:1901693),1/325,0.2554895831809807,0.2815028085978937,0,0,3.5689905591866378,4.870150440253562,MAP4K4
310,GO_Biological_Process_2017b,negative regulation of fat cell apoptotic process (GO:1904650),1/325,0.2554895831809807,0.2815028085978937,0,0,3.5689905591866378,4.870150440253562,MAP4K4
309,GO_Biological_Process_2017b,protein phosphorylation involved in mitotic spindle assembly (GO:1990801),1/323,0.2541255621135506,0.2815028085978937,0,0,3.591523565948118,4.92012436815058,MAP4K4
308,GO_Biological_Process_2017b,peptidyl-threonine phosphorylation (GO:0018107),1/320,0.2520751044887214,0.2815028085978937,0,0,3.625852848976581,4.996527482875349,MAP4K4
307,GO_Biological_Process_2017b,protein phosphorylation involved in DNA double-strand break processing (GO:1990802),1/312,0.2465811591588254,0.2815028085978937,0,0,3.7206355210894646,5.209128198481938,MAP4K4
306,GO_Biological_Process_2017b,protein phosphorylation involved in cellular protein catabolic process (GO:1902002),1/310,0.2452017295975243,0.2815028085978937,0,0,3.7450980392156863,5.264387020278373,MAP4K4
302,GO_Biological_Process_2017b,actin phosphorylation (GO:0031289),1/299,0.2375721301980589,0.2815028085978937,0,0,3.885511251480458,5.584583136164629,MAP4K4
315,GO_Biological_Process_2017b,negative regulation of epithelial cell apoptotic process (GO:1904036),1/325,0.2554895831809807,0.2815028085978937,0,0,3.5689905591866378,4.870150440253562,MAP4K4
316,GO_Biological_Process_2017b,negative regulation of muscle cell apoptotic process (GO:0010656),1/326,0.2561707098902637,0.2815028085978937,0,0,3.5578280542986427,4.84544595035529,MAP4K4
317,GO_Biological_Process_2017b,negative regulation of fibroblast apoptotic process (GO:2000270),1/326,0.2561707098902637,0.2815028085978937,0,0,3.5578280542986427,4.84544595035529,MAP4K4
318,GO_Biological_Process_2017b,peptidyl-tyrosine phosphorylation (GO:0018108),1/327,0.2568512480614547,0.2815028085978937,0,0,3.546734031035727,4.820927183584267,MAP4K4
319,GO_Biological_Process_2017b,negative regulation of mesenchymal cell apoptotic process (GO:2001054),1/327,0.2568512480614547,0.2815028085978937,0,0,3.546734031035727,4.820927183584267,MAP4K4
320,GO_Biological_Process_2017b,negative regulation of myeloid cell apoptotic process (GO:0033033),1/327,0.2568512480614547,0.2815028085978937,0,0,3.546734031035727,4.820927183584267,MAP4K4
321,GO_Biological_Process_2017b,JUN phosphorylation (GO:0007258),1/328,0.2575311981638886,0.2815028085978937,0,0,3.535707861126102,4.796592227940982,MAP4K4
322,GO_Biological_Process_2017b,negative regulation of glial cell apoptotic process (GO:0034351),1/330,0.2588893360476438,0.2815028085978937,0,0,3.513856606472376,4.748466227535915,MAP4K4
323,GO_Biological_Process_2017b,negative regulation of execution phase of apoptosis (GO:1900118),1/330,0.2588893360476438,0.2815028085978937,0,0,3.513856606472376,4.748466227535915,MAP4K4
324,GO_Biological_Process_2017b,negative regulation of leukocyte apoptotic process (GO:2000107),1/331,0.2595675248110448,0.2815028085978937,0,0,3.503030303030303,4.724671482583364,MAP4K4
305,GO_Biological_Process_2017b,pathway-restricted SMAD protein phosphorylation (GO:0060389),1/308,0.2438199149869709,0.2815028085978937,0,0,3.7698792872197737,5.320526315766718,MAP4K4
304,GO_Biological_Process_2017b,common-partner SMAD protein phosphorylation (GO:0007182),1/303,0.2403549184307445,0.2815028085978937,0,0,3.833268406700428,5.46485548614398,MAP4K4
301,GO_Biological_Process_2017b,inhibitory G-protein coupled receptor phosphorylation (GO:0002030),1/299,0.2375721301980589,0.2815028085978937,0,0,3.885511251480458,5.584583136164629,MAP4K4
293,GO_Biological_Process_2017b,positive regulation of gene expression (GO:0010628),1/282,0.22563751283129,0.2815028085978937,0,0,4.124136487335147,6.140119538546618,MYOM1
300,GO_Biological_Process_2017b,protein phosphorylation involved in protein localization to spindle microtubule (GO:1990803),1/298,0.2368749303387008,0.2815028085978937,0,0,3.898791839968311,5.615129669335532,MAP4K4
299,GO_Biological_Process_2017b,peptidyl-arginine phosphorylation (GO:0018109),1/298,0.2368749303387008,0.2815028085978937,0,0,3.898791839968311,5.615129669335532,MAP4K4
298,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998),1/298,0.2368749303387008,0.2815028085978937,0,0,3.898791839968311,5.615129669335532,MAP4K4
297,GO_Biological_Process_2017b,peptidyl-aspartic acid phosphorylation (GO:0018217),1/298,0.2368749303387008,0.2815028085978937,0,0,3.898791839968311,5.615129669335532,MAP4K4
296,GO_Biological_Process_2017b,peptidyl-histidine phosphorylation (GO:0018106),1/298,0.2368749303387008,0.2815028085978937,0,0,3.898791839968311,5.615129669335532,MAP4K4
295,GO_Biological_Process_2017b,peptidyl-cysteine phosphorylation (GO:0018218),1/298,0.2368749303387008,0.2815028085978937,0,0,3.898791839968311,5.615129669335532,MAP4K4
294,GO_Biological_Process_2017b,protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process (GO:1901044),1/292,0.2326790698433942,0.2815028085978937,0,0,3.980392156862745,5.803790528976996,BTBD9
303,GO_Biological_Process_2017b,histone phosphorylation (GO:0016572),1/303,0.2403549184307445,0.2815028085978937,0,0,3.833268406700428,5.46485548614398,MAP4K4
292,GO_Biological_Process_2017b,positive regulation of translation (GO:0045727),1/277,0.2220938910613629,0.2815028085978937,0,0,4.199914748508099,6.319422951921614,MYOM1
325,GO_Biological_Process_2017b,negative regulation of anoikis (GO:2000811),1/336,0.2629496856992922,0.2838382121333481,0,0,3.449868305531168,4.6083084646153685,MAP4K4
326,GO_Biological_Process_2017b,negative regulation of apoptotic signaling pathway (GO:2001234),1/338,0.2642984602347566,0.2839671828568781,0,0,3.429045208587886,4.56294913313209,MAP4K4
330,GO_Biological_Process_2017b,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/346,0.2696702831188067,0.2844467369883303,0,0,3.3481670929241263,4.387957927551578,MAP4K4
329,GO_Biological_Process_2017b,I-kappaB phosphorylation (GO:0007252),1/346,0.2696702831188067,0.2844467369883303,0,0,3.3481670929241263,4.387957927551578,MAP4K4
327,GO_Biological_Process_2017b,protein phosphorylation involved in double-strand break repair via nonhomologous end joining (GO:1990804),1/342,0.2669890191824064,0.2844467369883303,0,0,3.3881317923063654,4.4741898085462655,MAP4K4
328,GO_Biological_Process_2017b,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/344,0.2683308111180761,0.2844467369883303,0,0,3.368032927456697,4.430764152578589,BTBD9
331,GO_Biological_Process_2017b,peptidyl-serine phosphorylation (GO:0018105),1/352,0.2736748170671,0.287358557920455,0,0,3.2899279369867607,4.263136905121184,MAP4K4
332,GO_Biological_Process_2017b,protein autophosphorylation (GO:0046777),1/358,0.2776586069511354,0.2902223448222275,0,0,3.233646399736365,4.143474698078827,MAP4K4
334,GO_Biological_Process_2017b,torso signaling pathway (GO:0008293),1/371,0.286219469306234,0.2964874323306729,0,0,3.117965023847377,3.900562980397035,PTPRT
333,GO_Biological_Process_2017b,canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336),1/371,0.286219469306234,0.2964874323306729,0,0,3.117965023847377,3.900562980397035,MAP4K4
335,GO_Biological_Process_2017b,negative regulation of protein kinase activity by protein phosphorylation (GO:0100002),1/374,0.2881813989824237,0.2971870677006244,0,0,3.0924144456710296,3.8474742503303903,MAP4K4
81,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process (GO:0006511),1/341,0.2663172520343859,0.2987949656971159,0,0,3.398269896193772,4.496138770522036,BTBD9
336,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.2966243916293408,0.3045343754061232,0,0,2.9862846693081377,3.62919776036838,PTPRT
337,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process (GO:0043524),1/399,0.3043338981252007,0.3109962473774548,0,0,2.8944723618090453,3.443350667261196,MAP4K4
338,GO_Biological_Process_2017b,protein phosphorylation (GO:0006468),1/401,0.3056110309726504,0.3109962473774548,0,0,2.8797058823529413,3.4137246640835075,MAP4K4
82,GO_Biological_Process_2018,phosphorylation (GO:0016310),1/386,0.2959783035302231,0.3280723364431389,0,0,2.994194041252865,3.6453388031640617,MAP4K4
83,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.3024140385644269,0.3312153755705628,0,0,2.916902457185406,3.4884934470701143,PTPRT
84,GO_Biological_Process_2018,negative regulation of programmed cell death (GO:0043069),1/408,0.310063579763609,0.3330515271557661,0,0,2.829166064460182,3.312890955360751,MAP4K4
85,GO_Biological_Process_2018,vesicle-mediated transport (GO:0016192),1/410,0.3113307753847379,0.3330515271557661,0,0,2.815043865957141,3.2848728449197213,NCALD
86,GO_Biological_Process_2018,regulation of intracellular signal transduction (GO:1902531),1/422,0.3188879089964254,0.3372148003180591,0,0,2.733128405756602,3.12373514750615,NLRP11
339,GO_Biological_Process_2017b,negative regulation of apoptotic process (GO:0043066),1/467,0.3465354073616417,0.3510950837742949,0,0,2.463519313304721,2.6107645520149974,MAP4K4
340,GO_Biological_Process_2017b,DNA damage induced protein phosphorylation (GO:0006975),1/470,0.3483403695843184,0.3513826435544872,0,0,2.4473849241189014,2.580951454864819,MAP4K4
87,GO_Biological_Process_2018,protein phosphorylation (GO:0006468),1/470,0.3483403695843184,0.364174022747242,0,0,2.4473849241189014,2.580951454864819,MAP4K4
88,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),1/485,0.3572947717879314,0.369338415780783,0,0,2.3697131745260087,2.438894928379322,MAP4K4
89,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),1/506,0.3696358781774415,0.3778500088036068,0,0,2.2687245195107746,2.257918291811353,BTBD9
341,GO_Biological_Process_2017b,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/596,0.4200357721622747,0.4218620146499368,0,0,1.9166584280771133,1.6625390361275525,MAP4K4
90,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),1/771,0.5073392412269715,0.5129143977239712,0,0,1.46768525592055,0.9959350865712352,MYOM1
91,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.5272495434940525,0.5272495434940525,0,0,1.3851712675242087,0.886622260889506,MAP4K4
342,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1004,0.6044475151422631,0.6044475151422631,0,0,1.1130725470646885,0.5603657287085152,MYOM1
